The upcoming earnings report for Kenvue Inc. is scheduled for Wednesday, May 6th. Analysts estimate an earnings per share of $0.27.
Kenvue Inc. (KVUE) is currently priced at $17.77, showing an increase of 1.34% from the previous close. The trading volume is at $4.55 million, representing a 14.29% increase relative to the average.
In the latest quarterly earnings report on Monday, February 16th, Kenvue Inc. reported an earnings per share of $0.2227. The company is expected to release the latest quarterly revenue figures soon.
Kenvue Inc. offers a forward dividend yield of 4.67%, with a dividend per share of 20.75 cents in the most recent quarter. The year-over-year increase in dividend per share stands at 1.8519 cents.
Key financial ratios for Kenvue Inc. include a gross profit margin of 56.53%, return on equity of 3.07%, and a price-to-earnings ratio of 24.95. The company's debt-equity ratio is 79.18%, and the cash flow to debt ratio is at 10.0188 cents.
This report provides insights into KVUE's financial performance, upcoming earnings, dividend distribution, and key financial ratios for investors to consider.
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.